Corvus Pharmaceuticals (CRVS)'s 30-day implied volatility (IV30) was 65.6% at the close on November 4, 2026, down from 71.3% the day before, against a 52-week range of 44.8% to 191.3%. Its 20-day historical volatility was 60.6%.
Data as of November 4, 2026.